未登录

S

Sharmila A. Bapat

Savitribai Phule Pune University

H指数:21

被引数:3,259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Emergence and evolution of chimeric pseudogenes (φgenes) contribute to genetic and functional diversity of the human genome

嵌合假基因(φgenes)的出现和进化为人类基因组的遗传和功能多样性做出贡献

Nucleic Acids Research

IF13.1

2026-04-280

OA

Harnessing m6A-regulated cholesterol biosynthesis helps impede tumor burden and stemness in high-garde serous ovarian carcinoma mesenchymal phenotype

利用m6A调控的胆固醇生物合成有助于抑制高级别浆液性卵巢癌间质表型的肿瘤负荷和干性。

Molecular Medicine

IF6.4

2025-12-290

OAAI

Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells

靶向线粒体翻译和高等级浆液性卵巢癌中的OXPHOS可消除类干细胞细胞

Cell Death & Disease

IF9.6

2025-10-060

OA

Chimerism: A whole new perspective in gene regulation

嵌合现象：基因调控的一个全新视角

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

IF2.2

2025-03-010

PRE

A novel ITGB8 transcript variant sustains ovarian cancer cell survival through genomic instability and altered ploidy on a mutant p53 background

JOURNAL OF OVARIAN RESEARCH

IF4.2

2024-11-060

OAAI

NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2022-04-171

OA

RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2021-09-0922

PRE

Cellular plasticity and migratory modalities in high-grade serous ovarian carcinoma

CANCER RESEARCH

IF16.6

2019-07-010

OA

Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays

JOURNAL OF CLINICAL MEDICINE

IF2.9

2019-06-282

OAAI

Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines

IF2.9

2019-06-2515

OAAI

Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers

JOURNAL OF CLINICAL MEDICINE

IF2.9

2019-03-085

OAAI

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

PHARMACOLOGY & THERAPEUTICS

IF12.5

2019-02-01234

OAAI

Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays

FRONTIERS IN ONCOLOGY

IF3.3

2018-12-1823

OAAI

Phenotypic plasticity and class switching in ovarian cancer

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Tumor deconstruction as a tool for advanced drug screening and repositioning

PHARMACOLOGICAL RESEARCH

IF10.5

2016-09-013

PREAI

Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets

SCIENTIFIC REPORTS

IF3.9

2016-05-039

OAAI

Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer

CLINICAL CANCER RESEARCH

IF10.2

2015-11-1213

OAAI

Derivation of a fifteen gene prognostic panel for six cancers

SCIENTIFIC REPORTS

IF3.9

2015-08-1423

OAAI

A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses

IF7.3

2015-04-277

OAAI

Discrete Molecular Classes of Ovarian Cancer Suggestive of Unique Mechanisms of Transformation and Metastases

CLINICAL CANCER RESEARCH

IF10.2

2014-01-0536

OAAI